Karen Kaucic
Chief Tech/Sci/R&D Officer chez PPD, INC.
Profil
Karen Kaucic est médecin en chef et vice-présidente exécutive chez PPD, Inc. Le Dr Kaucic a obtenu un doctorat de l'Université d'État de l'Ohio.
Postes actifs de Karen Kaucic
Sociétés | Poste | Début |
---|---|---|
PPD, INC. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Karen Kaucic
Sociétés | Poste | Fin |
---|---|---|
Evidera, Inc.
Evidera, Inc. Miscellaneous Commercial ServicesCommercial Services Evidera, Inc. engages in provision of health economics, outcomes research, market access, data analytics and epidemiology services. It offers software for real-world data analytics, meta research, modeling and simulation, outcomes research, patient preferences, payer communications and strategy, precision and transformative technology solutions, and value and evidence planning. The company was founded in 2013 and is headquartered in Bethesda, MD. | President | - |
Formation de Karen Kaucic
The Ohio State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Evidera, Inc.
Evidera, Inc. Miscellaneous Commercial ServicesCommercial Services Evidera, Inc. engages in provision of health economics, outcomes research, market access, data analytics and epidemiology services. It offers software for real-world data analytics, meta research, modeling and simulation, outcomes research, patient preferences, payer communications and strategy, precision and transformative technology solutions, and value and evidence planning. The company was founded in 2013 and is headquartered in Bethesda, MD. | Commercial Services |
PPD, Inc.
PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |